Axiscades Technologies
- Market cap
- ₹ 8,154 Cr.
- P/E
- 248.3x
- P/B
- 11.46x
- 52-week range
- 1,063.3 – 2,360
- ROE
- 4%
- ROCE
- 4%
- Dividend yield
- 0%
- Debt / equity
- 0.53
- Sector
- Aerospace & Defense
- Industry
- Aerospace & Defense
- Listed on
- NSE, BSE
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Aerospace & Defense: 33 companies →Axiscades Technologies against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)248.3 against a typical 72.2: pricier than most peers (1st = cheapest).31st of 33
- Sales growth+94.7% against a typical +30.4% from a year earlier.5th of 28
- Profit growth−171.4% against a typical +8.9% from a year earlier.23rd of 27
- Share price, 3 months+26.1% against a typical −2%.9th of 32
- Size₹ 8,154.2 Cr. market value against a typical ₹ 4,442.2 Cr. (1st = largest).9th of 28
Latest announcements
Exchange filings and their impact on the company.
- Granted 2.46 lakh ESOPs at Rs 1,440, implying ~0.6% potential dilution with limited 12-month P&L impact.
AXISCADES Technologies granted 2,46,340 stock options to eligible employees under its ESOP 2018 Series 1 & 2 at an exercise price of Rs 1,440 per share, with an 8-year exercise window. Each option converts into one equity share on vesting. The grant implies about 0.6% potential dilution and a modest recurring ESOP charge, aiding retention with limited near-term financial impact.
- AXISCADES incorporated a space subsidiary with no financial details, implying negligible near-term impact.
AXISCADES Technologies incorporated a wholly-owned subsidiary, Xponential Space Private Limited, in India on October 16, 2026. The filing gives no authorised capital, investment amount, or business plan, with the detailed annexure not containing figures. For now this is a nominal incorporation with no meaningful revenue, profit or balance-sheet impact expected in the next 12 months.
- AXISCADES announced a planned CFO succession with new CFO-Designate joining Oct 2026 to take over in Jan 2027.
AXISCADES board on Oct 16, 2026 approved appointment of Uttam Kumar Bhageria as CFO-Designate with effect from Oct 21, 2026. Current Group CFO Shashidhar SK will attain superannuation on Dec 31, 2026, after which Bhageria will assume office as CFO and KMP from Jan 1, 2027. It is a planned succession with over two months of overlap, indicating continuity with no immediate operational or financial change.
- AXISCADES completed 100% acquisition of Swiss Ulosia Holding AG as wholly-owned subsidiary.
AXISCADES Technologies has completed the acquisition of 100% share capital of Ulosia Holding AG, Switzerland. Ulosia Holding became a wholly-owned subsidiary with effect from October 14, 2026. The filing follows an earlier intimation dated June 12, 2026 but gives no deal value or target financials.
- AXISCADES step-down to buy US precision-manufacturing assets for up to $7m to add US build capability for chip and data-centre clients.
AXISCADES board has approved in principle that its US step-down XIDA Inc will buy substantially all business assets of ITSJ Group Inc of San Jose for up to $7 million (~Rs 67 crore). The deal is $2.5m cash at close plus $2.5m in XIDA restricted shares and up to $2m earn-out, with closing expected by March 2027. ITSJ does precision machining, PCB assembly and box-build for semiconductor-equipment and data-centre clients with CY25 revenue of $3.47m (~Rs 33 crore), giving XIDA a US manufacturing base to scale.
- New deeptech subsidiary adds long-term optionality in semiconductors and AI with negligible near-term financial impact.
AXISCADES Technologies incorporated a step-down subsidiary, XIDA Deeptech Private Limited, in India on 5 October 2026 through XIDA Private Limited. The new entity will provide engineering, design, manufacturing and consulting services for electronics, semiconductor, AI and deep-tech industries. No investment amount or share subscription by the listed company was disclosed, with 0% direct holding and indirect control as ultimate holding company, indicating minimal near-term financial impact but a strategic push into high-growth tech verticals.
Credit ratings
Every rating action on file, newest first, including reaffirmations. Open a row for the agency's reasoning. All credit rating updates
Adequate safety
Rated A- by CARE- No warnings from the agency.
| Agency | Current rating | Outlook | As of |
|---|---|---|---|
| CARE | CARE A- (Rating Watch with Developing Implications) | — | 23 Jun 2026 |
| Rating | Details | |||||
|---|---|---|---|---|---|---|
| 23 Jun 2026 | Reaffirmed | CARE A- → CARE A- (Rating Watch with Developing Implications) | — | CARE | ₹ 101 Cr. | |
| 6 Oct 2025 | Reaffirmed | CARE A- | — | CARE | ₹ 101 Cr. |
Board meetings
Results dates and other board meetings. Full calendar
| Details | ||
|---|---|---|
| 5 Sep 2026 | Fund Raising | To consider and approve raising of funds by way of issuance of Secured, Unlisted, Redeemable, Non-Convertible Debentures (NCDs) for a value upto Rs. 200 crores. |
| 13 Aug 2026 | Financial Results | To consider and approve the unaudited financial results for the period ended June 30, 2026 |
| 27 May 2026 | Financial Results | To consider and approve the financial results for the period ended March 31, 2026 |
| 9 Feb 2026 | Financial Results | To consider and approve the unaudited financial results for the quarter and nine months ended December 31, 2025 |
| 12 Nov 2025 | Financial Results | To consider and approve the unaudited financial results for the quarter and half year ended September 30, 2025 |
| 7 Aug 2025 | Financial Results | To consider and approve the un-audited financial results for the Quarter ended Jun 30, 2025 |
Financials
Consolidated figures in ₹ crore.
| ₹ Cr. | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 252 | 232 | 256 | 224 | 265 | 275 | 268 | 94 | 299 | 343 | 109 | 183 |
| Expenses | 216 | 202 | 223 | 192 | 231 | 234 | 231 | 88 | 252 | 280 | 109 | 175 |
| Operating Profit | 37 | 30 | 32 | 31 | 33 | 40 | 37 | 7 | 47 | 63 | 0 | 9 |
| OPM % | 15% | 13% | 13% | 14% | 13% | 15% | 14% | 7% | 16% | 18% | 0.3% | 4.7% |
| Other Income | 1 | 2 | 5 | 10 | 4 | 1 | 2 | 27 | 6 | −6 | 20 | −5 |
| Interest | 12 | 12 | 13 | 8 | 9 | 7 | 8 | 6 | 7 | 7 | 9 | 9 |
| Depreciation | 9 | 8 | 10 | 9 | 10 | 11 | 10 | 5 | 10 | 11 | 10 | 9 |
| Profit before tax | 18 | 11 | 16 | 24 | 19 | 23 | 21 | 23 | 36 | 39 | 1 | −14 |
| Tax % | 36% | 32% | 44% | 31% | 35% | 36% | −47% | 7% | 36% | 29% | 44% | 4% |
| Net Profit | 11 | 8 | 9 | 17 | 12 | 15 | 32 | 21 | 23 | 28 | 0 | −15 |
| EPS in Rs | 2.88 | 1.93 | 2.08 | 4.07 | 2.91 | 3.49 | 7.24 | 4.88 | 5.42 | 6.52 | 0.1 | −3.49 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- 4%
- 5 Years
- 0%
- 3 Years
- −14%
- TTM
- 4%
- 10 Years
- 0%
- 5 Years
- −1%
- 3 Years
- 42%
- TTM
- −47%
- 10 Years
- 22%
- 5 Years
- 86%
- 3 Years
- 40%
- TTM
- —
- 10 Years
- 5%
- 5 Years
- 5%
- 3 Years
- 8%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Prices are delayed and for information only. Nothing on this page is investment advice.